Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Failed Dissolution Specifications
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an…
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an…
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Presence of foreign substance: Presence of Benzene.
Presence of foreign substance: Presence of Benzene.
CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug…
Cross Contamination
Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.
Cross Contamination
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Chemical Contamination: Presence of benzene
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit